BOSTON LIFE SCIENCES INC has a total of 16 patent applications. Its first patent ever was published in 1992. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Finland. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are CELGENE INTERNAT SARL, ENDOTIS PHARMA and KORIKSA CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Finland | 2 | |
#4 | Australia | 1 | |
#5 | Canada | 1 | |
#6 | Ireland | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Norway | 1 | |
#10 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Lanser Marc E | 6 |
#2 | Wiederschain Dmitri G | 5 |
#3 | Moses Marsha A | 5 |
#4 | Thorn Richard M | 5 |
#5 | Arora Sudershan K | 5 |
#6 | Thomson David S | 4 |
#7 | Akhtar M Nayeem | 3 |
#8 | Korpusik Mary A | 1 |
#9 | Sudershan Arora K | 1 |
#10 | Arora Sudershan | 1 |
Publication | Filing date | Title |
---|---|---|
WO2007053542A2 | Methods and compositions for the prevention and regression of neovascularization | |
WO03063890A1 | Troponin anti-metastatic therapeutic and method of use | |
WO0054770A1 | Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis | |
US6465431B1 | Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis | |
EP0715519A1 | Immunomodulatory, anti-inflammatory, and anti-proliferative compounds: 5,6-dideoxy, 5-amino derivatives of idose and 6-deoxy, 6-amino derivatives of glucose |